Terms: = Bone cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Clinical Outcome
9 results:
1. Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation.
Rovatti PE; Gambacorta V; Lorentino F; Ciceri F; Vago L
Front Immunol; 2020; 11():147. PubMed ID: 32158444
[TBL] [Abstract] [Full Text] [Related]
2. Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.
Shaw BE; Mayor NP; Szydlo RM; Bultitude WP; Anthias C; Kirkland K; Perry J; Clark A; Mackinnon S; Marks DI; Pagliuca A; Potter MN; Russell NH; Thomson K; Madrigal JA; Marsh SGE
Bone Marrow Transplant; 2017 May; 52(5):717-725. PubMed ID: 28092349
[TBL] [Abstract] [Full Text] [Related]
3. Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT.
Kosmoliaptsis V; Jöris MM; Mallon DH; Lankester AC; von dem Borne PA; Kuball J; Bierings M; Cornelissen JJ; Groenendijk-Sijnke ME; van der Holt B; Bradley JA; Oudshoorn M; van Rood JJ; Taylor CJ; Claas FH
Bone Marrow Transplant; 2015 Apr; 50(4):540-4. PubMed ID: 25621806
[TBL] [Abstract] [Full Text] [Related]
4. The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation.
Huo MR; Xu LP; Li D; Liu DH; Liu KY; Chen H; Han W; Chen YH; Wang Y; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Clin Transplant; 2012; 26(2):284-91. PubMed ID: 21919963
[TBL] [Abstract] [Full Text] [Related]
5. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian bone Marrow Donor Registry.
Crocchiolo R; Ciceri F; Fleischhauer K; Oneto R; Bruno B; Pollichieni S; Sacchi N; Sormani MP; Fanin R; Bandini G; Bonifazi F; Bosi A; Rambaldi A; Alessandrino PE; Falda M; Bacigalupo A
Bone Marrow Transplant; 2009 Nov; 44(9):571-7. PubMed ID: 19363528
[TBL] [Abstract] [Full Text] [Related]
6. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract] [Full Text] [Related]
7. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically hla-a, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
[TBL] [Abstract] [Full Text] [Related]
8. Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism.
Beelen DW; Ottinger HD; Elmaagacli A; Scheulen B; Basu O; Kremens B; Havers W; Grosse-Wilde H; Schaefer UW
Blood; 1997 Dec; 90(12):4725-35. PubMed ID: 9389688
[TBL] [Abstract] [Full Text] [Related]
9. The significance of HLA-DRB1 matching on clinical outcome after hla-a, B, DR identical unrelated donor marrow transplantation.
Petersdorf EW; Longton GM; Anasetti C; Martin PJ; Mickelson EM; Smith AG; Hansen JA
Blood; 1995 Aug; 86(4):1606-13. PubMed ID: 7632970
[TBL] [Abstract] [Full Text] [Related]
